Healthcare: A Surprising Reversal for Alkermes, Celldex's Super Bad News, and J&J's Q1 in Review

Industry Focus

The Motley Fool

Interview, Money, Consumergoods, Business, Businessnews, Ceo, Technology, Investing, Stocks, Energy, Fool, Financial, Economy, Healthcare, News, Banking, Motley, Tech, Business News, Investments

4.6 • 854 Ratings

🗓️ 18 April 2018

⏱️ 26 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Alkermes’ ALKS-5461 gets a do-over, Celldex's lead drug is a bust, and the good and bad of Johnson & Johnson's Q1 earnings report.

Thanks to Blooom for supporting Industry Focus. Get a month free with blooom401k.com/fool and code fool.

Transcript

Click on a timestamp to play from that location

0:00.0	Managing your 401k is hard.
0:02.2	Bloom isn't.
0:03.5	See what you could be doing to make your 401k better
0:06.2	by getting a free analysis at bloom 401k.com slash fool.
0:11.5	That's Bloom with 3 owes 401k.
0:14.3	dot com slash fool.
0:17.0	Welcome to Industry Focus, the podcast that dives into a different sector of
0:21.9	the stock market every day.
0:23.9	We're talking health care today April 18th.
0:26.4	My name is Christine Hargis and Todd Campbell, a full dot-com health care writer, is joining me
0:30.7	on the phone.
0:31.5	Hi Todd. Hi, Christine happy Wednesday. So as our
0:37.2	listeners and Todd you know I am just barely back from vacation and I'm
0:41.9	still fighting some serious jet lag so I'm only just
0:44.9	beginning to catch up on my health care news. So this episode is going to get us
0:49.9	all up to speed on what's been happening in the health care world over the last two weeks.
0:55.1	And Todd, I hope you're ready for me to lean on you for some crucial information.
0:59.0	Yep, absolutely.
1:01.2	More than happy to pitch in and help you and all of our listeners figure out at least a couple stories. I mean there were a number of different things that we could talk about today, but I was able to pick out a few that I think everybody will find
1:14.4	interesting. All right let's dive into the first one. All right for the first one you
1:20.0	gonna have to put the carbon reverse and back it up a little bit to going to the end of March, April 2nd actually was when they reported that they actually
1:30.1	got it.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.